Compliance with COVID-19 Mitigation Measures

Key facts

Disease
COVID-19
start year
2020
Funder
NWO Netherlands
Principal Investigator
Prof dr B van Rooij
Research Location
Netherlands
Lead Research Institution
Universiteit van Amsterdam
Research Priority Alignment
N/A

Research Category
Policies for public health, disease control & community resilience
Research Subcategory
Approaches to public health interventions
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified

Abstract

Until there is a vaccine or treatment, social distancing and stay at home orders are the most important measures to mitigate the effects of the Coronavirus. The crucial challenge is how to ensure that people will comply with these measures. This study gathers real-time data to assess, whether, to what extent, and why people comply. The data is vital for policy makers to increase the efficacy of these measures in attempting to contain the Coronavirus.

Publicationslinked via Europe PMC

Last Updated:7 hours ago

View all publications at Europe PMC

Developing injury and illness epidemiology and surveillance in cycling (PhD Academy Award).

Effects of Hand-Rearing and Group Size on Chimpanzee (Pan troglodytes) Social Competence in Captivity.

Revisiting Spirituality in Physical Therapy Practice: Perceptions of US Practitioners.

Aflibercept for Wet Age-Related Macular Degeneration: A Prospective, Randomized Trial Comparing Treat-And-Extend and Fixed Bimonthly Dosing.

The Concentration and Duration of Lipopolysaccharide Stimulation Produce Different Cytokine Responses in an Ex Vivo Whole Blood Model in Horses.

History of Shrimp Farming and the Main Viral and Bacterial Diseases in Mexico.

Identification of Risk Factors in Patients with Recurrent Cystitis May Improve Individualized Management.

ISApl4, a New IS1595 Family Insertion Sequence Forming a Novel Pseudo-Compound Transposon That Confers Antimicrobial Multidrug Resistance in Actinobacillus pleuropneumoniae.